-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, O/nbSnb+5EX2bZ3mffx3iSYmp34kN/yQ/unzJoJHfLew5J6pLfZqm0yJHKqWVjMh 9j/2Lyc8d4y21QawuNfHog== 0001374170-10-000031.txt : 20101015 0001374170-10-000031.hdr.sgml : 20101015 20101015081413 ACCESSION NUMBER: 0001374170-10-000031 CONFORMED SUBMISSION TYPE: SC 13G PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20101015 DATE AS OF CHANGE: 20101015 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: AMAG PHARMACEUTICALS INC. CENTRAL INDEX KEY: 0000792977 STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835] IRS NUMBER: 042742593 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G SEC ACT: 1934 Act SEC FILE NUMBER: 005-38286 FILM NUMBER: 101124739 BUSINESS ADDRESS: STREET 1: 100 HAYDEN AVENUE CITY: LEXINGTON STATE: MA ZIP: 02140 BUSINESS PHONE: 6174972070 MAIL ADDRESS: STREET 1: 100 HAYDEN AVENUE CITY: LEXINGTON STATE: MA ZIP: 02140 FORMER COMPANY: FORMER CONFORMED NAME: ADVANCED MAGNETICS INC DATE OF NAME CHANGE: 19920703 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: Norges Bank CENTRAL INDEX KEY: 0001374170 IRS NUMBER: 000000000 STATE OF INCORPORATION: Q8 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G BUSINESS ADDRESS: STREET 1: BANKPLASSEN2 STREET 2: P.O BOX 1179 SENTRUM CITY: OSLO STATE: Q8 ZIP: 0107 BUSINESS PHONE: 004724073120 MAIL ADDRESS: STREET 1: BANKPLASSEN2 STREET 2: P.O BOX 1179 SENTRUM CITY: OSLO STATE: Q8 ZIP: 0107 SC 13G 1 efc10-1510_formsc13g.txt DISCLOSURE >5% UNITED STATES SECURITIES EXCHANGE COMMISSION Washington, D.C. 20549 - ------------------------------------------------------------------------------- SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. )* AMAG Pharmaceuticals, Inc. ---------------------------------------------- (Name of Issuer) Common Stock, par value USD 0.01 per share ----------------------------------------------------- (Title of Class of Securities) 00163U106 --------------------- (CUSIP Number) October 12, 2010 ---------------- (Date of Event which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Schedule is filed: [ ] Rule 13d-1(b) [X] Rule 13d-1(c) [ ] Rule 13d-1(d) * The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page. The information required in the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes). Continued on following pages Page 1 of 5 Pages SCHEDULE 13G CUSIP No.: 00163U106 Page 2 of 5 Pages ................................................................................. 1. Names of Reporting Persons. I.R.S. Identification Nos. of above persons (entities only). NORGES BANK (THE CENTRAL BANK OF NORWAY) ................................................................................. 2. Check the Appropriate Box if a Member of a Group (a) [ ] (b) [ ] N/A ................................................................................. 3. SEC Use Only ................................................................................. 4. Citizenship or Place of Organization NORWAY ................................................................................. Number of 5. Sole Voting Power 1,071,374 Shares Beneficially ................................................................ Owned by Each Reporting 6. Shared Voting Power 0 Person With ................................................................ 7. Sole Dispositive Power 317,857 ................................................................ 8. Shared Dispositive Power 753,517 ................................................................................. 9. Aggregate Amount Beneficially Owned by Each Reporting Person 1,071,374 ................................................................................. 10. Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions) N/A ................................................................................. 11. Percent of Class Represented by Amount in Row (9) 5.09% based on 21,050,459 issued Common Stock ................................................................................. 12. Type of Reporting Person: OO CUSIP No.: 00163U106 Page 3 of 5 Pages Item 1(a). Name of Issuer: AMAG Pharmaceuticals, Inc. (the "Issuer"). Item 1(b). Address of Issuer's Principal Executive Offices: 100 Hayden Avenue Lexington, MA 02421 United States of America Item 2(a). Name of Person Filing: This Statement is filed on behalf of each of the following persons (collectively, the "Reporting Persons"): NORGES BANK (CENTRAL BANK OF NORWAY) Item 2(b). Address of Principal Business Office or, if None, Residence: Bankplassen 2 PO Box 1179 Sentrum NO 0107 Oslo Norway Item 2(c). Citizenship: Norwegian Item 2(d). Title of Class of Securities: Common Stock, par value USD 0.01 per share Item 2(e). CUSIP Number: 00163U106 Item 3. If This Statement is Filed Pursuant to ss.ss.240.13d-1(b) or 240.13d-2(b) or (c), Check Whether the Person Filing is a: This Item 3 is not applicable. Item 4. Ownership: Item 4(a) Amount Beneficially Owned As of October 12, 2010, Norges Bank may be deemed to be the beneficial owner of 1,071,374 Common shares. Item 4(b) Percent of Class: The number of Shares which Norges Bank may be deemed to be the beneficial owner of constitutes approximately 5.09% of the total number of Common Stock in issue. Page 4 of 5 Pages Item 4(c) Number of Shares of which such person has: NORGES BANK (CENTRAL BANK OF NORWAY) (i) Sole power to vote or direct the vote: 1,071,374 (ii) Shared power to vote or direct the vote: 0 (iii) Sole power to dispose or direct the disposition of: 317,857 (iv) Shared power to dispose or direct the disposition of: 753,517 Item 5. Ownership of Five Percent or Less of a Class: This Item 5 is not applicable. Item 6. Ownership of More than Five Percent on Behalf of Another Person: This Item 6 is not applicable. Item 7. Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on By the Parent Holding Company: This Item 7 is not applicable. Item 8. Identification and Classification of Members of the Group: This Item 8 is not applicable. Item 9. Notice of Dissolution of Group: This Item 9 is not applicable. Item 10. Certification: By signing below each of the Reporting Persons certifies that, to the best of their knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect. Page 5 of 5 Pages SIGNATURE After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct. NORGES BANK Date: October 15, 2010 By: /s/ Jonas Lexmark ---------------------- Name: Jonas Lexmark Title: Analyst -----END PRIVACY-ENHANCED MESSAGE-----